Clinical Trials: The Features And Promises Of The Brazilian Market

Main Category: Clinical Trials / Drug Trials
Also Included In: Pharma Industry / Biotech Industry
Article Date: 21 Sep 2008 - 0:00 PDT

email to a friend   printer friendly   opinions  

Frost & Sullivan will host a live briefing on Tuesday, September 23, at 3:00 pm EDT to provide industry participants an overview of a recently published study focusing on Clinical Trials Markets in Brazil.

Over the years, Brazil has increasingly raised its attractiveness for pharmaceutical clinical trials and outsourcing due to cost advantages, considerable patient pool and quality resources. Furthermore, expiring patents, and consequent increasing presence of generics drugs, and fiercely competition are compelling pharmaceutical companies to raise R&D investments and improve the speed of new drugs launching. From the challenges of pharmaceutical companies, to the need of developing new drugs for new diseases, to the increasing and aging population, these companies are setting themselves up to take advantage of promising market dynamics in Brazil.

Highlights of the briefing include analyses of: Clinical Trials market overview and profile, structure and processes, outsourcing, major challenges and trends and growth opportunities.

This briefing will benefit market participants, companies interested in participate in this market, hospitals and healthcare institutions by discussing emerging trends, market opportunities and challenges and providing a complete overview despite forward projections for the Pharmaceutical Clinical Trials Market in Brazil.

"Higher costs, competition from generics, and lack of productivity from R&D have been challenging pharmaceutical companies worldwide to better manage R&D costs and deadlines as well as improve quality of the whole drug discovery process," observes Daniela Putti, Industry Analyst at Frost & Sullivan. "To responsibly address these issues, pharmaceutical and biotech companies are seeking for more accessible and efficient clinical trial locations such as emerging countries like Brazil. Here these companies and Contract Research Organizations (CROs) may likely find promising market features and growth opportunities for clinical trials."

Frost & Sullivan will hold this live briefing at 2:00 PM CDT / 3:00 PM EDT on Tuesday, September 23, 2008, which will provide industry participants an outlook on the Brazilian Pharmaceutical Clinical Trials Market. To participate, please e-mail José María Jantus at jose.jantus@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be e-mailed to you.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

Frost & Sullivan